Investing

Allstate, Booking, CyberArk, Hilton and More Thursday Afternoon Analyst Calls

With the trading day about halfway over, the broad markets were somewhat mixed. The Dow Jones industrial average and S&P 500 each posted a handy gain, while the Nasdaq was barely in the red.

24/7 Wall St. is looking at some big analyst calls seen so far on Thursday. We have included the latest analyst call on each stock, as well as a recent trading history and the consensus targets among analysts.

For those that might have missed it, 24/7 Wall St. had an earlier round of analyst calls on Thursday that included Apple, Darden Restaurants, Peloton, Pfizer, Tilray and more.

Allstate Corp. (NYSE: ALL): JPMorgan’s upgrade to an Overweight rating from Positive included a price target hike to $134 from $130. The stock traded around $130 on Thursday. The 52-week trading range is $84.97 to $131.66. Its consensus analyst target is $133.00.

Booking Holdings Inc. (NASDAQ: BKNG): Barclays reiterated its Overweight rating and raised its price target to $2,740 from $2,710. Credit Suisse reiterated it as Outperform but lowered its price target to $2,675 from $2,740. The shares changed hands at around $2,275 on Thursday. The 52-week trading range is $1,303.25 to $2,516.00. The consensus price target is $2,487.04.

Chemours Co. (NYSE: CC): Argus upgraded it to a Buy rating from Hold and has a $40 price target. The shares traded near $33 on Thursday, in a 52-week trading range of $10.62 to $34.23. The consensus price target is $34.11.

CyberArk Software Ltd. (NASDAQ: CYBR): Baird reiterated an Outperform rating and lowered its price target to $160 from $170. Shares were trading around $114, in the 52-week range of $92.61 to $169.70. The consensus price target is $179.78.

Evolus Inc. (NASDAQ: EOLS): Mizuho upgraded the stock to a Buy rating from Neutral and has a $15 price target. The stock traded near $9 on Thursday, in a 52-week range of $2.85 to $17.38. It has a consensus price target of $17.22.

Hilton Worldwide Holdings Inc. (NYSE: HLT): Morgan Stanley reiterated its Equal Weight rating and raised its price target to $110 from $101. Raymond James reiterated it at Outperform and hiked its price target from $125 to $135. The stock traded near $121 on Thursday, in a 52-week range of $62.47 to $132.69. It has a consensus price target of $124.67.

Kratos Defense & Security Solutions Inc. (NASDAQ: KTOS): The Noble Capital Markets upgrade to Outperform from Market Perform comes with a $30 price target. The stock traded near $26 on Thursday, in a 52-week range of $14.40 to $34.11. It has a consensus price target of $28.67.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE): Evercore ISI upgraded the shares to Outperform from In-Line, and the firm has a $144 price target. While Citigroup upgraded it to a Buy rating from Neutral, the analyst lowered its $160 price target to $151. On Thursday, the stock traded around $112. The 52-week trading range is $61.96 to $179.65. Its consensus analyst target is $153.19.


Four quality Jefferies stock picks have value characteristics but also appear to have the hidden potential for momentum stock upside. Two of them are technology names that were hit hard this week and look especially attractive.

See why one top analyst sees plenty of upside in Peloton despite the sell-off.